A.-S. Peaucelle, “An Unusual Skin Adverse Event after Switching from Intravenous to Subcutaneous VEDOLIZUMAB Therapy in Patients with Ulcerative Colitis”, acmcr, vol. 7, no. 1, pp. 77–79, Feb. 2023.